Resist the temptation to accelerate
Last reviewed: July 9, 2026 Last updated: July 9, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Patients in the dose-escalation phase have increased risk of gastric emptying delay, and this phase often lasts four to eight weeks
At Olivera, youll talk to real people who help you get past all the chatter and focus on what will actually move you forward
Endogenous hepcidin and its agonist mediate resistance to selected infections by clearing non-transferrin-bound iron
About the study The current observational study estimates the average treatment effect of continuous GLP-1 receptor agonist use on suicidal ideation, self-harm, and suicide among T2D patients